Christopher B. Primiano
2014
In 2014, Christopher B. Primiano earned a total compensation of $2.2M as Senior Vice President, Corporate Development, General Counsel and Secretary at Karyopharm Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $60,500 |
|---|---|
| Option Awards | $1,871,595 |
| Salary | $213,750 |
| Other | $7,982 |
| Total | $2,153,827 |
Primiano received $1.9M in option awards, accounting for 87% of the total pay in 2014.
Primiano also received $60.5K in non-equity incentive plan, $213.8K in salary and $8K in other compensation.
Rankings
In 2014, Christopher B. Primiano's compensation ranked 4,221st out of 13,032 executives tracked by ExecPay. In other words, Primiano earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,221 out of 13,032 | 68th |
Division Manufacturing | 1,489 out of 4,965 | 70th |
Major group Chemicals And Allied Products | 487 out of 1,690 | 71st |
Industry group Drugs | 377 out of 1,369 | 73rd |
Industry Pharmaceutical Preparations | 301 out of 1,042 | 71st |
Source: SEC filing on April 29, 2016.
Primiano's colleagues
We found four more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2014.
2014
Justin Renz
Karyopharm Therapeutics
Chief Financial Officer
2014
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Worldwide Development Operations
2014
Michael Kauffman
Karyopharm Therapeutics
Chief Executive Officer
2014
Sharon Shacham
Karyopharm Therapeutics